This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Bluefin Biomedicine, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Svetlana Popova: Innovator in Antibody Drug Conjugates
Introduction
Svetlana Popova is a prominent inventor based in Andover, MA (US). She has made significant contributions to the field of biomedicine, particularly in the development of innovative antibody drug conjugates. With a total of two patents to her name, her work is paving the way for advancements in cancer treatment.
Latest Patents
Svetlana's latest patents focus on anti-V-set domain containing T cell activation inhibitor 1 (VTCN1) antibodies and antibody drug conjugates (ADCs). These patents disclose compositions and methods for using these antibodies and ADCs, which have the potential to enhance the efficacy of cancer therapies.
Career Highlights
Svetlana is currently employed at Bluefin Biomedicine, Inc., where she continues to push the boundaries of medical research. Her expertise in antibody development is instrumental in the company's mission to create targeted therapies for cancer patients.
Collaborations
Svetlana collaborates with notable colleagues, including Ailan Guo and Scott Michael Lonning. These partnerships foster a dynamic research environment that encourages innovation and the sharing of ideas.
Conclusion
Svetlana Popova's contributions to the field of biomedicine through her patents and work at Bluefin Biomedicine, Inc. highlight her role as a leading inventor in the development of advanced cancer therapies. Her ongoing research promises to make a significant impact on the future of medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile